Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children

Pediatrics

Volumn 117, Issue 3, 2006, Pages 729-740

  Bagenda, Danstan ^a,c   Nassali, Annette ^a   Kalyesubula, Israel ^a   Sherman, Becky ^b   Drotar, Dennis ^b   Boivin, Michael J ^b,d   Olness, Karen ^b,e  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d INDIANA WESLEYAN UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Africa; AIDS; Children; Cognitive ability; HIV; Intelligence; K ABC; Kaufman Assessment Battery for Children; Motor development; Neuropsychology; Pediatrics; Social development

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CHILD; COGNITION; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NERVOUS SYSTEM DEVELOPMENT; OTITIS MEDIA; PAROTITIS; PRIORITY JOURNAL; PSYCHOMETRY; RECALL; SOCIOECONOMICS; UGANDA; UPPER RESPIRATORY TRACT INFECTION; CHILD DEVELOPMENT; COHORT ANALYSIS; DEVELOPMENTAL DISORDER; FOLLOW UP; INTELLIGENCE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SURVIVOR;

ANTI-RETROVIRAL AGENTS; CHILD; CHILD DEVELOPMENT; COGNITION; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HIV INFECTIONS; HIV-1; HUMANS; INTELLIGENCE; MALE; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PSYCHOMOTOR PERFORMANCE; SURVIVORS; UGANDA;

EID: 33645034753     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2004-2699     Document Type: Article

References (48)

1. Drotar D, Olness K, Wiznitzer M, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics. 1997;100(1). Available at: www.pediatrics.org/cgi/content/ full/100/1/e5
2. Ultmann MH, Diamond GW, Ruff HA, et al. Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study. Int J Neurosci. 1987;32:661-667
3. Condini A, Axia G, Cattelan C, et al. Development of language in 18-30-month-old HIV-1-infected but not ill children. AIDS. 1991;5:735-739
4. Levenson RL Jr, Mellins CA, Zawadzki R, Kairam R, Stein Z. Cognitive assessment of human immunodeficiency virus-exposed children. Am J Dis Child. 1992;146:1479-1483
5. Boivin MJ, Green SDR, Davies AG, Giordani B, Mokili JKL, Cutting WAM. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol. 1995;14:13-21
6. Diamond GW, Gurdin P, Wiznia AA, Belman AL, Rubinstein A, Cohen HJ. Effects of congenital HIV infection on neurodevelopmental status of babies in foster care. Dev Med Child Neurol. 1990;32:999-1005
7. Bisiacchi PS, Suppiej A, Laverda A. Neuropsychological evaluation of neurologically asymptomatic HIV infected children. Brain Cogn. 2000;43:49-52
8. Bruck I, Tahan TT, da-Cruz CR, et al. Developmental milestones of vertically HIV infected and seroreverter children. Arq Neuropsiquiatr. 2001;59:691-695
9. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effects of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics. 1994;94:883-891
10. Price DB, Inglese CM, Jacobs J, et al. Pediatric AIDS: neuroradiologic and neurodevelopmental findings. Pediatr Radiol. 1988;18:445-448
11. Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome: neurologic syndromes. Am J Dis Child. 1988;142:29-35
12. Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev. 2001;7:211-216
13. Brouwers P, Wolters P, Civitello L. Central nervous system manifestations and assessment. In: Pizzo PA, Wilfert CMn, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999:293-308
14. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics. 1999;104(5). Available at: www.pediatrics.org/cgi/content/ full/104/5/e56
15. Zijenah L, Mbizvo MT, Kasule J, et al. Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe. J Infect Dis. 1998;178:109-113
16. Crampin AC, Floyd S, Glynn JR, et al. The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS. 2003;17:389-397
17. Ryder RW, Nsuami M, Nsa W, et al. Morality in HIV-1 seropositive women, their spouses, and their newly born children during 36 months of follow-up in Kinshasha, Zaire. AIDS. 1994;8:667-672
18. Drotar D, Olness K, Wiznitzer M, et al. Neurodevelopmental outcomes of Ugandan infants with HIV infection, an application of growth curve analysis. Health Psychol. 1999;19:1-8
19. Kalyesubula I, Musoke-Mudido P, Marum L, Bagenda D, Ndugwa C, Olness K. Effects of malaria infection in HIV-1 infected Ugandan children. Pediatr Infect Dis J. 1997;16:876-881
20. Peterson NJ, Drotar D, Olness K, Guay L, Kiziri-Mayengo R. The relationship of maternal and child HIV infection to security of attachment among Ugandan infants. Child Psychiatry Hum Dev. 2001;32:3-17
21. Mandalakas A, Guay L, Musoke P, Carrol-Pankhurst C, Olness K. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Pediatrics. 1999;103(2). Available at: www.pediatrics.org/cgi/content/full/103/2/e21
22. Neely M, Kalyesubula I, Bagenda D, Myers C, Olness K. Cord blood chloroquine levels and HIV transmission in Ugandan infants. Afr Health Sci. 2003;3:6
23. Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997;100(1). Available at: www.pediatrics.org/cgi/content/full/100/1/e7
24. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children: Administration and Scoring Manual. Circle Pines, MN: American Guidance Services Inc; 1983
25. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children: Interpretive Manual. Circle Pines, MN: American Guidance Services Inc; 1983
26. Boivin MJ, Giordani B. Improvements in cognitive performance for school children in Zaire, Africa following an iron supplement and treatment for intestinal parasites. J Pediatr Psychol. 1993;18:249-264
27. Boivin MJ, Giordani B, Kisoki N, et al. Effects of treatment for intestinal parasites and malaria on the cognitive abilities of school children in Zaire, Africa. Health Psychol. 1993;12:220-226
28. Marum L, Bagenda D, Guay L. Three year mortality in a cohort of HIV-1 infected and uninfected Ugandan children [abstract]. XIth International Conference on AIDS STD, Vancouver, British Columbia, Canada; July 7-12, 1996. Abstract WeB 312
29. World Health Organization. The world health report 2003. Available at: www.who.int/whr/2003/en/index.html. Accessed December 22, 2005
30. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802
31. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-868
32. The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra Study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359:1178-1186
33. Diamond GW, Kaufman J, Belman AL, Cohen L, Cohen HJ, Rubinstein A. Characterization of cognitive functioning in a subgroup of children with congenital HIV infection. Arch Clin Neuropsychol. 1987;2:245-256
34. Frank E, Foley G, Gilbert M, Kuchuk A. Cognitive functioning in school-age children with human immunodeficiency virus. Percept Mot Skills. 1997;85:267-272
35. Pulsifer MB, Aylward EH. Human immunodeficiency virus. In: Yeates KO, Ris MD, eds. Pediatric Neuropsychology: Research, Theory, and Practice. New York, NY: Guilford Press; 2000:381-402. The Science and Practice of Neuropsychology: A Guilford Series
36. Henry RR, Christensen BK, Coscia JM, Cohen F, Moore E. Relationship between cognitive and immune functioning in children born to HIV-1 seropositive women. Dev Neurospsychol. 1996;12:283-298
37. Rausch DM, Stover ES. Neuroscience research in AIDS. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:231-257
38. Tardieu M, Mayaux M, Seibel N, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr. 1995;126:375-379
39. Blanchette N, Smith ML, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infections. Brain Cogn. 2001;46:50-53
40. Fishkin P, Armstrong F, Routh D, et al. Brief report: relationship between HIV infection and WPPSI-R performance in preschool-age children. J Pediatr Psychol. 2000;25:347-351
41. Smith R, Malee K, Charurat M, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J. 2000;19:862-871
42. Pollack H, Kuchuk A, Cowan L, et al. Neurodevelopment, growth, and viral load in HIV-infected infants. Brain Behav Immunol. 1996;10:298-312
43. Fair C, Spencer E, Wiener L, Riekert K. Healthy children in families affected by AIDS: epidemiological and psychosocial considerations. Child Adolesc Social Work J. 1995;12:165-181
44. Kullgren K, Morris MK, Bachanas PJ, Jones J. Prediction of cognitive, adaptive, and behavioral functioning in preschool and school-age children with HIV. Child Health Care. 2004;33:241-256
45. Coscia J, Christensen B, Henry R, Wallston K, Radcliffe J, Rutstein R. Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection. J Pediatr Psychol. 2001;26:321-329
46. Mellins C, Levenson R, Zawadzki R, Kairam R, Weston M. Effects of pediatric HIV infection and prenatal drug exposure on mental and psychomotor development. J Pediatr Psychol. 1994;19:617-627
47. Foster G, Williamson J. A review of current literature on the impact of HIV/AIDS on children in sub-Saharan Africa. AIDS. 2000;14:S275-S284
48. Nozyce M, Hoberman M, Arpadi S, Wiznia A. A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children. AIDS. 1994;8:635-639